📝 Jyothy Labs Limited — results explained
Quarter ended December 2025 (Q3 FY26)
Jyothy Labs Limited reported revenue of ₹740 crore for the quarter ended December 2025 (Q3 FY26), up 5.0% from ₹704 crore in the same quarter last year, and up 0.5% sequentially over the September 2025 quarter.
Net profit fell 7.2% year-on-year to ₹81 crore, from ₹87 crore. Earnings per share (EPS) came in at ₹2.21.
Operating profit stood at ₹111 crore — an operating margin (OPM) of 15.0%, compared with 16.4% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Jyothy Labs Limited posted revenue of ₹2,227 crore, a decline of 21.8% over FY25, with a net profit of ₹266 crore (down 28.3% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹2,894 crore with a net profit of ₹342 crore.
Valuation snapshot
At the current price of ₹190.15, JYOTHYLAB has a market capitalisation of ₹6,983 crore and a trailing P/E of about 20.4.
Within the Personal Care - Indian industry, it is the largest of the 4 companies we track by market value.
Shareholding pattern
As of Sep 2026, promoters held 62.89%, foreign institutional investors (FIIs) 14.48%, domestic institutional investors (DIIs) 9.86%, the government 0.01%, public shareholders 12.77% of Jyothy Labs Limited.